Neuroblastoma in adults: Incidence and survival analysis based on SEER data

Pediatric Blood & Cancer
Natia EsiashviliPeter A S Johnstone

Abstract

Clinical data on survival outcomes of adult patients (defined as 20 years of age and older) with neuroblastoma are scarce due to the rarity of the disease. Small single institution reports have described worse outcomes for adults than pediatric patients. Data from the public access Surveillance Epidemiology and End Results database were reviewed for a 30-year period between 1973 and 2002 for the diagnosis of neuroblastoma. Analyses compared frequency and survival rates of neuroblastoma among children and adults with particular focus on the incidence, case characteristics, and long-term survival of the adult patients. The observed 3- and 5-year survival rates were lowest among adult patients (45.9% and 36.3%, respectively), whereas infants fared best with 86.0% 3-year and 84.6% 5-year overall survival. There was a steady decline in the incidence of adult neuroblastoma from 0.47 cases per million per year in 1973-1977 to 0.12 cases per million per year in 1998-2002. When the long-term adult neuroblastoma survival was examined in detail for 1-, 3-, 5-, 7-, and 10-year follow-up periods, there was continuous decrease in survival during the first 7 years after the diagnosis with subsequent stabilization for both observed (OS) and re...Continue Reading

References

Sep 1, 1989·International Journal of Radiation Oncology, Biology, Physics·B R Prestidge, S S Donaldson
Dec 1, 1987·American Journal of Epidemiology·S DavisT W Pendergrass
Sep 1, 1984·Southern Medical Journal·B P Grubb, M Thant
Mar 1, 1980·Cancer·R LopezU Rao
Dec 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B H KushnerN K Cheung
Aug 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G M BrodeurF Hedborg
Aug 1, 1997·Pediatric Clinics of North America·R P Castleberry
Nov 5, 2003·Medical and Pediatric Oncology·Brian H KushnerNai-Kong V Cheung
Jan 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Jianqing FanYi Ren
Apr 22, 2004·Genes, Chromosomes & Cancer·Junko TakitaHiroyuki Aburatani

❮ Previous
Next ❯

Citations

Jan 19, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Victoria CastelRosa Noguera
Oct 7, 2011·Clinical Nuclear Medicine·Xinchong ShiZhifeng Chen
Jul 27, 2012·Future Oncology·Jennifer GainsMark Gaze
Jul 9, 2014·World Journal of Surgery·Nezar Y JrebiDavid R Farley
May 23, 2013·Expert Opinion on Emerging Drugs·Victoria CastelPablo Berlanga
May 28, 2013·Urology·Albert TiuPeter Aslan
Oct 16, 2015·Annals of Surgical Oncology·Benjamin C JamesRaymon H Grogan
Feb 24, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Gemma GattaUNKNOWN RARECARE Working Group
Aug 1, 2014·Neoplasia : an International Journal for Oncology Research·Ana P BerbegallRosa Noguera
Feb 23, 2010·Current Problems in Cancer·Natia EsiashviliHoward M Katzenstein
Mar 6, 2016·Clinical Radiology·C A MacielA Sahdev
May 12, 2009·International Journal of Radiation Oncology, Biology, Physics·Jeffrey A ForquerPeter A S Johnstone
Oct 20, 2010·Pediatric Annals·Surabhi BatraRadhika Peddinti
Aug 19, 2014·The Journal of Obstetrics and Gynaecology Research·Chisa ShimadaTadashi Hasegawa
Sep 8, 2012·Case Reports in Medicine·Micaela PellegrinoGiorgio Borretta
May 13, 2015·World Journal of Surgical Oncology·Ory WieselCiaran McNamee
Mar 27, 2015·Journal of Korean Neurosurgical Society·Mehmet Osman AkcakayaNail Izgi
Nov 21, 2013·Korean Journal of Pathology·Go Eun BaeJung-Sun Kim
Apr 24, 2014·Journal of Pediatric Hematology/oncology·Ehssan Al-FarajAbha Gupta
Apr 5, 2013·Toxicology and Industrial Health·Elanur AydinMevlüt Sait Keles
Mar 8, 2018·São Paulo Medical Journal = Revista Paulista De Medicina·Fazli YanikYener Yoruk
May 20, 2015·The Cochrane Database of Systematic Reviews·Frank PeinemannFrank Berthold
Mar 27, 2018·International Journal of Cancer. Journal International Du Cancer·Maya SuzukiShakeel Modak
May 17, 2019·Immunotherapy·Parnian JabbariNima Rezaei
Mar 19, 2014·Journal of Pediatric Hematology/oncology·Stefania SorrentinoBruno De Bernardi
Nov 22, 2019·Genes, Chromosomes & Cancer·Kai DuanCatherine T Chung
May 2, 2020·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Krystal GarrovilloHarminder Sikand
Jul 7, 2017·Clinical Nuclear Medicine·Dharmender MalikBhagwant Rai Mittal
Jun 11, 2019·International Journal of Oncology·Yongbo YuXin Ni
Mar 14, 2014·International Journal of Cancer. Journal International Du Cancer·Nicolas WentzensenMark E Sherman
Apr 13, 2019·BMJ Case Reports·Jason RamsinghCarol Watson
Jul 28, 2019·Medicine·Yan-Bin TanRun-Lin Yang
Sep 11, 2019·Journal of Medical Case Reports·Haibin Zhang, Ziwei Feng
Dec 14, 2018·International Journal of Surgical Pathology·Alyaa Al-IbraheemiKaren J Fritchie

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Computer Assisted Tomography
Ukihide TateishiNoriyuki Moriyama
The New England Journal of Medicine
Edward F AttiyehChildren's Oncology Group
The New England Journal of Medicine
Alice L YuChildren's Oncology Group
© 2022 Meta ULC. All rights reserved